| Submit your comments on this article |
| -Lurid Crime Tales- |
| Epipen Maker’s Stock Value Drops Nearly $3 Billion In 5 Days As Investors Panic |
| 2016-08-28 |
| [USUNCUT] Mylan Pharmaceuticals — the company behind the price gouging of the EpiPen — is experiencing serious karmic retribution in the stock market. In just five days, Mylan’s stock has tanked by 12.4 percent as outrage over its astronomical price increases of the life-saving EpiPen has reached a boiling point. Mylan’s stock price went from a high of $49.20 per share on August 19 to $43.11 on August 24, according to MarketWatch |
| Posted by:Fred |
| #5 Worse than you think bit not surprising. SLL |
| Posted by: Alaska Paul 2016-08-28 20:50 |
| #4 The FDA just rejected the Teva Pharmaceuticals generic equivalent. There's been a recall on another generic device on the market (correctly so -- there was a non-zero chance that when actuated the device would deliver no drug). I don't think Mylan is shaking in their shoes, though Heather Bresch may want to go up a half-size on her stilettos for a while... |
| Posted by: Steve White 2016-08-28 13:57 |
| #3 Mylan has a patent on the delivery system, and herein lies the rub (or Market Value enhancement, depending upon your viewpoint.). Think MS Operating Systems, McDonald's "Secret Sauce," paint formulations, etc. The price of EpiPen will take a temporary hit until their Marketing Department *spit* can come up with something to oil the waters. A generic is on the way, and Epi is required to maximize their return (Shareholder Value) until (and after) that day. “Often, price increases are taken at the end” of a product’s patent life, he said. “So that was just consistent with what most companies do.” |
| Posted by: Blossom Unains5562 2016-08-28 11:42 |
| #2 Government Bailout in 5, 4, 3, 2...... |
| Posted by: Mullah Richard 2016-08-28 10:53 |
| #1 closed 8-25 at ~43 |
| Posted by: lord garth 2016-08-28 08:25 |